生物
癌症研究
基因敲除
甲基化
癌变
前列腺癌
转移RNA
效应器
翻译(生物学)
生物发生
癌症
核糖核酸
计算生物学
细胞生物学
遗传学
细胞培养
信使核糖核酸
基因
作者
Raquel García-Vílchez,Ana M. Añazco-Guenkova,Sabine Dietmann,Judith López,Virginia Morón-Calvente,Silvia D’Ambrosi,Paz Nombela,Kepa Zamacola,Isabel Mendizabal,Saioa Garcia‐Longarte,Amaia Zabala‐Letona,Ianire Astobiza,Sonia Fernández,Alejandro Paniagua,Borja Miguel‐López,Virginie Marchand,Diego Alonso‐López,Angelika Merkel,Ignacio García‐Tuñón,Aitziber Ugalde‐Olano
出处
期刊:Molecular Cancer
[BioMed Central]
日期:2023-07-29
卷期号:22 (1): 119-119
被引量:116
标识
DOI:10.1186/s12943-023-01809-8
摘要
Abstract Newly growing evidence highlights the essential role that epitranscriptomic marks play in the development of many cancers; however, little is known about the role and implications of altered epitranscriptome deposition in prostate cancer. Here, we show that the transfer RNA N 7 -methylguanosine (m 7 G) transferase METTL1 is highly expressed in primary and advanced prostate tumours. Mechanistically, we find that METTL1 depletion causes the loss of m 7 G tRNA methylation and promotes the biogenesis of a novel class of small non-coding RNAs derived from 5'tRNA fragments. 5'tRNA-derived small RNAs steer translation control to favour the synthesis of key regulators of tumour growth suppression, interferon pathway, and immune effectors. Knockdown of Mettl1 in prostate cancer preclinical models increases intratumoural infiltration of pro-inflammatory immune cells and enhances responses to immunotherapy. Collectively, our findings reveal a therapeutically actionable role of METTL1-directed m 7 G tRNA methylation in cancer cell translation control and tumour biology.
科研通智能强力驱动
Strongly Powered by AbleSci AI